The Amgen Bioprocessing Center Advisory Board (ABCAB) consists of scientists, engineers, academics, and corporate executives who provide support and advice to KGI’s Amgen Bioprocessing Center.
Principal Project Manager, R&D, Genentech, Inc.
Ashraf Amanullah, PhD
EVP, Technical Operations, InhibRx
SVP, Quality and Compliance, Coherus Biosciences (ABCAB Chair 2015-2016)
Robert Baffi, PhD
President of Global Manufacturing and Technical Operations, BioMarin Pharmaceutical, Inc. (ABCAB Chair 2014)
Head of Product Management Cell Culture Technologies, Sartorius Stedim North America, Inc.
Vijay Chivuloru, PhD
SVP of Global Process Development – Cell Therapy, Kite Pharma, A Gilead Sciences Company
Jon Coffman, PhD
Senior Director of Bioprocess Technology and Engineering, AstraZeneca
Larry A. Couture, PhD
CEO and Director, Orbsen Therapeutics, LTD
Semsi Ensari, PhD
Director, Kite Pharma, A Gilead Sciences Company
Tina Etcheverry, PhD
Owner/Founder, EtchWave Consulting
Dennis M. Fenton, PhD
Principal, Fenton & Associates LLC
Scientific Director, Irvine Scientific
Nuno Fontes, PhD
Executive Director and Site Head of Process Science, Boehringer-Ingelheim
Erik Fouts, PhD
Vice President, Novato Manufacturing, BioMarin Pharmacteutical, Inc. (ABCAB Chair 2017-2018)
VP, Bioprocess Technogies, Broadley-James Corporation
Founder and CEO, Celltheon Corporation
Sam Guhan, PhD
VP, Process Development, Amgen, Inc.
Vice President of Process Development, Amgen, Inc.
Robert Johnson, PhD
Chief Operating Officer, GenVivo, Inc.
Robert Kiss, PhD
Vice President Process & Analytical Development, Sutro Biopharma
Rajesh Krishnan, PhD
Senior V.P., Process Development and Manufacturing, Oncternal Therapeutics
Head of Scientific Operations, Blue Note Therapeutics
Gargi Maheshwari, PhD
Associate Vice President, Merck and Company, Inc.
Associate Director, CMC Team Leader, Juno Therapeutics, A Cellgene Company
Senior Vice President, Engineering, ISP – Integrated Project Services, LLC
Senior Advisor, Amgen, Inc.
Executive Vice President, Chief Technical Operations Officer, Atara BioTherapeutics
Vice President, Device Technologies
Vinit Saxena, PhD
President and CEO, Separagen Corporation
Abhinav Shukla, PhD
Vice President & Head, Manufacturing, CRISPR Therapeutics
Chariman & CEO, Saccharo, Inc.
Jay Stout, PhD
Gordon Vehar, PhD
Vice President of Research, BioMarin Pharmacteutical, Inc.
Vic Vinci, PhD
Vice President, Product Development, Catalent Biologics (ABCAB Chair 2019-2020)
Weichang Zhou, PhD
VP, WuXi AppTec Co., Ltd.
Mark Zimmerman, PhD
Vice President, Business Development and Strategy, Interim Vice President, Operations, ViaCyte